Literature DB >> 1723542

Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RA-) CD4-positive T cells.

L K Ashman1, G W Aylett.   

Abstract

The CD31 antigen, a member of the immunoglobulin superfamily with a possible cell adhesion function, is expressed on approximately 50% of peripheral blood lymphoid cells at relatively low intensity (10-20% of the level on monocytes). In the accompanying paper we showed that a mAb, 5A2.G5, which identifies a glycosylation-dependent epitope of the CD31 antigen, bound to fewer lymphocytes than two other CD31 mAb, B2B1 and 2BD4, although the 3 antibodies bound equally well to monocytes. We have now analyzed the pattern of expression of epitopes of the CD31 antigen on lymphoid cell subpopulations using two-color immunofluorescence and flow cytometry. Large granular lymphocytes (CD16+), CD8-positive T cells and B cells (SMIg+) were mostly CD31-positive as indicated by the binding of mAb B2B1 and 2BD4. Single populations displaying some overlap with the negative control were obtained in each case. In contrast, CD4-positive T cells fell into two discrete populations with respect to CD31 antigen expression. mAb 5A2.G5 displayed weaker binding to all lymphoid cell types, indicating that the pattern of glycosylation of the CD31 antigen differs between lymphocytes (of all types) and cells of the myeloid lineages. The heterogeneity of CD31 antigen expression by CD4-positive cells was further examined by dual-labelling of purified CD4 cells with mAb B2B1 and CD45RA or CD29 mAb which identify naive and memory T cells respectively. The CD31 antigen was found to be preferentially expressed by the CD45RA-positive, naive cell population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723542     DOI: 10.1111/j.1399-0039.1991.tb01899.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

1.  Switched at birth: a new family for PECAM-1.

Authors:  P J Newman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

2.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells.

Authors:  C E Demeure; D G Byun; L P Yang; N Vezzio; G Delespesse
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors.

Authors:  Yin Ge; Susan Cheng; Martin G Larson; Anahita Ghorbani; Roderick P Martin; Rachael J Klein; Christopher J O'Donnell; Ramachandran S Vasan; Stanley Y Shaw; Thomas J Wang; Kenneth S Cohen
Journal:  Atherosclerosis       Date:  2013-04-22       Impact factor: 5.162

5.  Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders.

Authors:  M Marazuela; F Sánchez-Madrid; A Acevedo; E Larrañaga; M O de Landázuri
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

6.  Imaging of vascular development in early mouse decidua and its association with leukocytes and trophoblasts.

Authors:  B Anne Croy; Zhilin Chen; Alexander P Hofmann; Edith M Lord; Abigail L Sedlacek; Scott A Gerber
Journal:  Biol Reprod       Date:  2012-11-29       Impact factor: 4.285

7.  CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.

Authors:  Ewan A Ross; Ruth E Coughlan; Adriana Flores-Langarica; Saeeda Bobat; Jennifer L Marshall; Khiyam Hussain; James Charlesworth; Nikita Abhyankar; Jessica Hitchcock; Cristina Gil; Constantino López-Macías; Ian R Henderson; Mahmood Khan; Steve P Watson; Ian C M MacLennan; Christopher D Buckley; Adam F Cunningham
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

8.  CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.

Authors:  Jessica A Hutter Saunders; Katherine A Estes; Lisa M Kosloski; Heather E Allen; Kathryn M Dempsey; Diego R Torres-Russotto; Jane L Meza; Pamela M Santamaria; John M Bertoni; Daniel L Murman; Hesham H Ali; David G Standaert; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-11       Impact factor: 4.147

9.  Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution.

Authors:  P J Newman; C A Hillery; R Albrecht; L V Parise; M C Berndt; A V Mazurov; L C Dunlop; J Zhang; S E Rittenhouse
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

10.  Structural Basis for Human PECAM-1-Mediated Trans-homophilic Cell Adhesion.

Authors:  Menglong Hu; Hongmin Zhang; Qun Liu; Quan Hao
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.